Editor: What To Know
- Michael Kreindel, InMode Chief Technology Officer, and inventor of Evoke commented, “The idea of a facial hands-free treatment has been circulating in the market for about 8 years.
- Evoke is the first hands-free device for the face and submental area cleared by the FDA.
- I’m proud that InMode, after years of research and development, is the first company to bring this solution to patients worldwide.
InMode Ltd. today announced Evoke, a breakthrough non-invasive solution for facial remodeling.
Evoke is the first hands-free device for the face and submental area cleared by the FDA. This advanced radiofrequency-based platform addresses patient aesthetic concerns with uniform and controlled heating of the skin and subdermal tissue.
Dr. Michael Kreindel, InMode Chief Technology Officer, and inventor of Evoke commented, “The idea of a facial hands-free treatment has been circulating in the market for about 8 years. I’m proud that InMode, after years of research and development, is the first company to bring this solution to patients worldwide.”
“Evoke delivers the ultimate solution in thermal facial procedures. Patients can not only turn back the hands of time but are now also able to achieve long-lasting structural enhancements to their face without excisional surgery. InMode once again has brought to market another aesthetics industry game changer,” said Dr. Spero Theodorou, InMode Chief Medical Officer and Plastic Surgeon (bodySCULPT, NY).
